FRAMINGHAM, MA -- (MARKET WIRE) -- March 23, 2007 -- Symbollon Pharmaceuticals, Inc. (OTCBB: SYMBA) today announced financial results for the year ended December 31, 2006. The Company reported a net loss of $(3,046,784), or $(0.36) per share, compared with a net loss of $(645,973), or $(0.09) per share, in the prior year.
